Xeris Biopharma Holdings, Inc. (XERS) Operating Lease, Payments USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Xeris Biopharma Holdings, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2022 to 2024.
  • Xeris Biopharma Holdings, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $365 K, a 23.6% decline year-over-year.
  • Xeris Biopharma Holdings, Inc. Operating Lease, Payments for the twelve months ending March 31, 2024 was $1.54 M, a 30% decline year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Operating Lease, Payments for 2023 was $1.65 M, a 23.7% decline from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.54 M $365 K -$113 K -23.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.65 M $365 K -$112 K -23.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $1.76 M $365 K -$259 K -41.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.02 M $440 K -$173 K -28.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.19 M $478 K +$33 K +7.42% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.16 M $477 K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $624 K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $613 K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $445 K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.